Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chackalamannil

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Current Topics in Medicinal Chemistry|May 29, 2003
G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agentsSamuel Chackalamannil
Expert Opinion on Therapeutic Patents|February 11, 2010
Thrombin receptor (PAR-1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia
Current Opinion in Drug Discovery & Development|June 30, 2009
Personalized medicine: a paradigm for a sustainable pharmaceutical industry?Samuel Chackalamannil, Manoj C Desai
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variationsSamuel Chackalamannil, Darío Doller, Robert McQuade, et al.
Analytical Chemistry|April 26, 2003
Direct plasma analysis of drug compounds using monolithic column liquid chromatography and tandem mass spectrometryYunsheng Hsieh, Ganfeng Wang, Yuguang Wang, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Potent non-peptide thrombin receptor antagonistsSamuel Chackalamannil, Ho-Sam Ahn, Yan Xia, et al.
Current Pharmaceutical Design|October 8, 2003
Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseasesHo-Sam Ahn, Samuel Chackalamannil, George Boykow, et al.
Journal of Medicinal Chemistry|March 28, 2008
Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore modelHongwu Wang, Ruth A Duffy, George C Boykow, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2009
The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitorsSanthosh F Neelamkavil, Craig D Boyle, Samuel Chackalamannil, et al.
Journal of the American Chemical Society|September 28, 2006
Total synthesis of (-)-himgalineUnmesh Shah, Samuel Chackalamannil, Ashit K Ganguly, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Topics in Medicinal Chemistry|May 29, 2003
G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agentsSamuel Chackalamannil
Expert Opinion on Therapeutic Patents|February 11, 2010
Thrombin receptor (PAR-1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia
Current Opinion in Drug Discovery & Development|June 30, 2009
Personalized medicine: a paradigm for a sustainable pharmaceutical industry?Samuel Chackalamannil, Manoj C Desai
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variationsSamuel Chackalamannil, Darío Doller, Robert McQuade, et al.
Analytical Chemistry|April 26, 2003
Direct plasma analysis of drug compounds using monolithic column liquid chromatography and tandem mass spectrometryYunsheng Hsieh, Ganfeng Wang, Yuguang Wang, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 20, 2004
Potent non-peptide thrombin receptor antagonistsSamuel Chackalamannil, Ho-Sam Ahn, Yan Xia, et al.
Current Pharmaceutical Design|October 8, 2003
Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseasesHo-Sam Ahn, Samuel Chackalamannil, George Boykow, et al.
Journal of Medicinal Chemistry|March 28, 2008
Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore modelHongwu Wang, Ruth A Duffy, George C Boykow, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2009
The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitorsSanthosh F Neelamkavil, Craig D Boyle, Samuel Chackalamannil, et al.
Journal of the American Chemical Society|September 28, 2006
Total synthesis of (-)-himgalineUnmesh Shah, Samuel Chackalamannil, Ashit K Ganguly, et al.
Pageof 5